Observational studyBMC cancer2023

Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study.

Katsuhiko Nara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.